A randomised trial of [ 18 F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.

Karen Middelbo Buch-Olsen,Mads Hvid Poulsen,Steinbjørn Hansen,Mie Holm Vilstrup,Jorun Holm,Søren Hess,Paw Christian Holdgaard,Karsten Egbert Arnold Zieger, Søren Sørensen Madsen,Oke Gerke,Kasper Tholstrup Pedersen,Johan Hygum Dam,Niels Langkjær,Louise Dorner Østergaard,Jon Thor Asmussen,Poul Erik Braad,Birgitte Nørgaard,Matthias Eiber,Malene Grubbe Hildebrandt

BJUI Compass（2023）

引用 0|浏览6

暂无评分

摘要

The Regional Committees on Health Research Ethics for Southern Denmark (S-20190161) and the Danish Medicines Agency (EudraCT Number 2021-000123-12) approved the study, and it has been registered on clinicaltrials.gov (Record 2020110469).

查看译文

关键词

primary prostate cancer,progression‐free survival,PSMA‐PET/CT,quality of life,staging

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要